aluates Reports

$ 0.0

Automative

Aflibercept Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-36C10591

Global and United States Aflibercept Drug Market Report Forecast 2022 2028

BUY CHAPTERS

Aflibercept Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36C10591

Report

October 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Regeneron

Bayer

Sanofi

Aflibercept Drug - Market Size

The global market for Aflibercept Drug was estimated to be worth US$ 5617 million in 2023 and is forecast to a readjusted size of US$ 7305.9 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030

Aflibercept Drug - Market

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer.

The Eylea market is primarily driven by the increasing prevalence of retinal diseases and the demand for effective treatments. Eylea (aflibercept) is a medication used to treat various eye conditions, including wet age-related macular degeneration (AMD) and diabetic macular edema. The growing aging population and the rise in chronic diseases like diabetes contribute to market growth. Moreover, advancements in ocular therapeutics and the demonstrated efficacy of Eylea in improving visual outcomes further propel adoption. However, challenges include managing the high cost of treatment and ensuring equitable access to care. Navigating the competitive landscape, optimizing treatment protocols, and addressing potential side effects are ongoing concerns. The market's success relies on continuous research to expand the indications for Eylea, collaborations between pharmaceutical manufacturers and ophthalmologists, and comprehensive patient education on the benefits and potential risks of treatment while addressing the evolving challenges associated with retinal disease management and treatment affordability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aflibercept Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aflibercept Drug by region & country, by Type, and by Application.

The Aflibercept Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aflibercept Drug.

Market Segmentation

Scope of Aflibercept Drug - Market Report

Report Metric	Details
Report Name	Aflibercept Drug - Market
Forecasted market size in 2030	US$ 7305.9 million
CAGR	3.8%
Forecasted years	2024 - 2030
Segment by Type:	Prefilled Syring Package Vial Package
Segment by Application	Eye Disease Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Regeneron, Bayer, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aflibercept Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aflibercept Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aflibercept Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Aflibercept Drug - Market size in 2030?

Ans: The Aflibercept Drug - Market size in 2030 will be US$ 7305.9 million.

Who are the main players in the Aflibercept Drug - Market report?

Ans: The main players in the Aflibercept Drug - Market are Regeneron, Bayer, Sanofi

What are the Application segmentation covered in the Aflibercept Drug - Market report?

Ans: The Applications covered in the Aflibercept Drug - Market report are Eye Disease, Cancer

What are the Type segmentation covered in the Aflibercept Drug - Market report?

Ans: The Types covered in the Aflibercept Drug - Market report are Prefilled Syring Package, Vial Package

1 Market Overview

1.1 Aflibercept Drug Product Introduction

1.2 Global Aflibercept Drug Market Size Forecast

1.2.1 Global Aflibercept Drug Sales Value (2019-2030)

1.2.2 Global Aflibercept Drug Sales Volume (2019-2030)

1.2.3 Global Aflibercept Drug Sales Price (2019-2030)

1.3 Aflibercept Drug Market Trends & Drivers

1.3.1 Aflibercept Drug Industry Trends

1.3.2 Aflibercept Drug Market Drivers & Opportunity

1.3.3 Aflibercept Drug Market Challenges

1.3.4 Aflibercept Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Aflibercept Drug Players Revenue Ranking (2023)

2.2 Global Aflibercept Drug Revenue by Company (2019-2024)

2.3 Global Aflibercept Drug Players Sales Volume Ranking (2023)

2.4 Global Aflibercept Drug Sales Volume by Company Players (2019-2024)

2.5 Global Aflibercept Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Aflibercept Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Aflibercept Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Aflibercept Drug

2.9 Aflibercept Drug Market Competitive Analysis

2.9.1 Aflibercept Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Aflibercept Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflibercept Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Prefilled Syring Package

3.1.2 Vial Package

3.2 Global Aflibercept Drug Sales Value by Type

3.2.1 Global Aflibercept Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Aflibercept Drug Sales Value, by Type (2019-2030)

3.2.3 Global Aflibercept Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Aflibercept Drug Sales Volume by Type

3.3.1 Global Aflibercept Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Aflibercept Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Aflibercept Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Aflibercept Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Eye Disease

4.1.2 Cancer

4.2 Global Aflibercept Drug Sales Value by Application

4.2.1 Global Aflibercept Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Aflibercept Drug Sales Value, by Application (2019-2030)

4.2.3 Global Aflibercept Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Aflibercept Drug Sales Volume by Application

4.3.1 Global Aflibercept Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Aflibercept Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Aflibercept Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Aflibercept Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Aflibercept Drug Sales Value by Region

5.1.1 Global Aflibercept Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Aflibercept Drug Sales Value by Region (2019-2024)

5.1.3 Global Aflibercept Drug Sales Value by Region (2025-2030)

5.1.4 Global Aflibercept Drug Sales Value by Region (%), (2019-2030)

5.2 Global Aflibercept Drug Sales Volume by Region

5.2.1 Global Aflibercept Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Aflibercept Drug Sales Volume by Region (2019-2024)

5.2.3 Global Aflibercept Drug Sales Volume by Region (2025-2030)

5.2.4 Global Aflibercept Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Aflibercept Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Aflibercept Drug Sales Value, 2019-2030

5.4.2 North America Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Aflibercept Drug Sales Value, 2019-2030

5.5.2 Europe Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Aflibercept Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Aflibercept Drug Sales Value, 2019-2030

5.7.2 South America Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Aflibercept Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Aflibercept Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Aflibercept Drug Sales Value

6.2.1 Key Countries/Regions Aflibercept Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Aflibercept Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Aflibercept Drug Sales Value, 2019-2030

6.3.2 United States Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Aflibercept Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Aflibercept Drug Sales Value, 2019-2030

6.4.2 Europe Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Aflibercept Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Aflibercept Drug Sales Value, 2019-2030

6.5.2 China Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Aflibercept Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Aflibercept Drug Sales Value, 2019-2030

6.6.2 Japan Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Aflibercept Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Aflibercept Drug Sales Value, 2019-2030

6.7.2 South Korea Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Aflibercept Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Aflibercept Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Aflibercept Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Aflibercept Drug Sales Value, 2019-2030

6.9.2 India Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Aflibercept Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Regeneron

7.1.1 Regeneron Company Information

7.1.2 Regeneron Introduction and Business Overview

7.1.3 Regeneron Aflibercept Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Regeneron Aflibercept Drug Product Offerings

7.1.5 Regeneron Recent Development

7.2 Bayer

7.2.1 Bayer Company Information

7.2.2 Bayer Introduction and Business Overview

7.2.3 Bayer Aflibercept Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Bayer Aflibercept Drug Product Offerings

7.2.5 Bayer Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Aflibercept Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Aflibercept Drug Product Offerings

7.3.5 Sanofi Recent Development

8 Industry Chain Analysis

8.1 Aflibercept Drug Industrial Chain

8.2 Aflibercept Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Aflibercept Drug Sales Model

8.5.2 Sales Channel

8.5.3 Aflibercept Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Regeneron

Bayer

Sanofi

List of Tables

Table 1. Aflibercept Drug Market Trends

Table 2. Aflibercept Drug Market Drivers & Opportunity

Table 3. Aflibercept Drug Market Challenges

Table 4. Aflibercept Drug Market Restraints

Table 5. Global Aflibercept Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Aflibercept Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Aflibercept Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Aflibercept Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Aflibercept Drug Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Aflibercept Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Aflibercept Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Aflibercept Drug

Table 13. Global Aflibercept Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflibercept Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Aflibercept Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Aflibercept Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Aflibercept Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Aflibercept Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Aflibercept Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Aflibercept Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Aflibercept Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Aflibercept Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Aflibercept Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Aflibercept Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Aflibercept Drug Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Aflibercept Drug Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Aflibercept Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Aflibercept Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Aflibercept Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Aflibercept Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Aflibercept Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Aflibercept Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Aflibercept Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Aflibercept Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Aflibercept Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Aflibercept Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Aflibercept Drug Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Aflibercept Drug Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Aflibercept Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Aflibercept Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Aflibercept Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Aflibercept Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Aflibercept Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Aflibercept Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Aflibercept Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Aflibercept Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Aflibercept Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Aflibercept Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Aflibercept Drug Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Aflibercept Drug Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Aflibercept Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Aflibercept Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Aflibercept Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Aflibercept Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Aflibercept Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Regeneron Company Information

Table 58. Regeneron Introduction and Business Overview

Table 59. Regeneron Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Regeneron Aflibercept Drug Product Offerings

Table 61. Regeneron Recent Development

Table 62. Bayer Company Information

Table 63. Bayer Introduction and Business Overview

Table 64. Bayer Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Bayer Aflibercept Drug Product Offerings

Table 66. Bayer Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Aflibercept Drug Product Offerings

Table 71. Sanofi Recent Development

Table 72. Key Raw Materials Lists

Table 73. Raw Materials Key Suppliers Lists

Table 74. Aflibercept Drug Downstream Customers

Table 75. Aflibercept Drug Distributors List

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Aflibercept Drug Product Picture

Figure 2. Global Aflibercept Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Aflibercept Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Aflibercept Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Aflibercept Drug Sales Price (2019-2030) & (US$/Unit)

Figure 6. Aflibercept Drug Report Years Considered

Figure 7. Global Aflibercept Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Aflibercept Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Aflibercept Drug Revenue in 2023

Figure 10. Aflibercept Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Prefilled Syring Package Picture

Figure 12. Vial Package Picture

Figure 13. Global Aflibercept Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Aflibercept Drug Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Aflibercept Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Aflibercept Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Aflibercept Drug Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Eye Disease

Figure 19. Product Picture of Cancer

Figure 20. Global Aflibercept Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Aflibercept Drug Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Aflibercept Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Aflibercept Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Aflibercept Drug Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Aflibercept Drug Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Aflibercept Drug Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Aflibercept Drug Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Aflibercept Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Aflibercept Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Aflibercept Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Aflibercept Drug Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Aflibercept Drug Sales Volume (%), (2019-2030)

Figure 37. United States Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 43. China Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 45. China Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 55. India Aflibercept Drug Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Aflibercept Drug Sales Value by Type (%), 2023 VS 2030

Figure 57. India Aflibercept Drug Sales Value by Application (%), 2023 VS 2030

Figure 58. Aflibercept Drug Industrial Chain

Figure 59. Aflibercept Drug Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions